Drug Development
Krystal Biotech doses first subject in lung cancer drug trial
The open-label, multicentre study will assess the drug's safety and tolerability in patients with solid lung tumours.
The open-label, multicentre study will assess the drug's safety and tolerability in patients with solid lung tumours.